IL6 and neoplasm: In an orthotopic nude endometrial carcinoma model, IL6 promoted tumour growth [37], while targeted inhibition of the IL6 receptor dramatically reduced tumour growth in HEC1A cell-derived subcutaneous xenografts in immune-deficient mice [38].